Dactinomycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 55150-431

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dactinomycin (NDC 55150-431). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dactinomycin-fig1 (Dactinomycin Fig1)

FDA Label Image

Dactinomycin-fig2 (Dactinomycin Fig2)

Dactinomycin-fig2 (Dactinomycin Fig2)
This is a pharmaceutical product description for Dactinomycin, a lyophilized injection used for the treatment of cancer. It comes in a single-dose vial of 500mg that must be reconstituted before administration. The package provides detailed instructions on how to prepare the solution for intravenous injection. The product label also includes precautionary measures, dosage information, and storage instructions. The manufacturer is Auromedics Pharma LLC and is produced in India.*
FDA Label Image

Dactinomycin-str (Dactinomycin Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.